Guy Berchem

Latest publications

Identification of beta-arrestin-1 as a diagnostic biomarker in lung cancer.

  • Discovery Proteomics
  • Competence Center for Methodology and Statistics
  • Bioinformatics and Modelling
  • Clinical and Epidemiological Investigation Center
August 06, 2018
2018 Aug. Br J Cancer. [Epub ahead of print].
By:
  • El-Khoury V
  • Beland M
  • Schritz A
  • Kim SY
  • Nazarov PV
  • Gaboury L
  • Sertamo K
  • Bernardin F
  • Batutu R
  • Antunes L
  • Bennett CW
  • Fays F
  • Berchem G
  • Kim YJ.

Inhibition of HIF1alpha-dependent upregulation of Phospho-l-Plastin resensitizes multiple myeloma cells to frontline therapy.

  • Tumor Microenvironment
  • Bioinformatics and Modelling
  • Laboratory of Oncolytic-Virus-Immuno-Therapeutics
May 23, 2018
2018 May. Int J Mol Sci.19(6):1551.
By:
  • Bosseler M
  • Marani V
  • Broukou A
  • Lequeux A
  • Kaoma T
  • Schlesser V
  • François J-H
  • Palissot V
  • Berchem G
  • Aouali N
  • Janji B.

CD47 is a direct target of SNAI1 and ZEB1 and its blockade activates the phagocytosis of breast cancer cells undergoing EMT.

  • Tumor Microenvironment
  • Bioinformatics and Modelling
February 15, 2018
2018 Feb. OncoImmunology.7(4):e1345415. In press.
By:
  • Noman MZ
  • Van Moer K
  • Marani V
  • Gemmill RM
  • Tranchevent LC
  • Azuaje F
  • Muller A
  • Chouaib S
  • Thiery JP
  • Berchem G
  • Janji B.